Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution
 Back to Profile

Jessica Donington

Concepts (361)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
43
2020
901
11.630
 Why?
Lung Neoplasms
62
2020
2046
11.090
 Why?
Pneumonectomy
18
2020
178
6.060
 Why?
Neoplasm Staging
33
2020
1900
3.090
 Why?
Thoracic Surgery
6
2020
30
2.830
 Why?
Osteopontin
6
2013
51
2.400
 Why?
Radiosurgery
8
2018
207
2.030
 Why?
Physicians, Women
4
2020
46
1.700
 Why?
Adenocarcinoma
11
2016
1225
1.440
 Why?
Pleural Neoplasms
11
2016
180
1.410
 Why?
Humans
107
2021
77711
1.380
 Why?
Mesothelioma
13
2016
292
1.330
 Why?
Esophagectomy
5
2009
83
1.320
 Why?
Early Detection of Cancer
2
2020
281
1.270
 Why?
Small Cell Lung Carcinoma
3
2020
79
1.150
 Why?
Disease Management
3
2019
310
1.070
 Why?
Tomography, X-Ray Computed
11
2020
2511
1.010
 Why?
Catheter Ablation
6
2015
281
0.980
 Why?
Neoplasm Recurrence, Local
10
2017
1140
0.940
 Why?
Specialties, Surgical
1
2020
52
0.880
 Why?
Antibody Formation
1
2020
200
0.870
 Why?
Societies, Medical
3
2020
500
0.840
 Why?
Antibodies, Viral
2
2021
305
0.840
 Why?
Surgical Flaps
3
2017
260
0.820
 Why?
Esophageal Neoplasms
4
2009
359
0.810
 Why?
Carcinoma, Squamous Cell
5
2016
1015
0.790
 Why?
Neoplasms, Second Primary
5
2016
225
0.780
 Why?
Thoracic Surgical Procedures
2
2019
39
0.770
 Why?
Mass Screening
2
2020
607
0.750
 Why?
Probability
1
2017
350
0.700
 Why?
Skin Ulcer
1
2016
23
0.700
 Why?
Salvage Therapy
2
2017
215
0.690
 Why?
Frozen Sections
1
2015
46
0.650
 Why?
Skin Transplantation
1
2016
166
0.640
 Why?
Combined Modality Therapy
10
2019
1640
0.630
 Why?
Esophagus
2
2006
116
0.610
 Why?
Monitoring, Intraoperative
1
2015
140
0.600
 Why?
Female
40
2021
42391
0.600
 Why?
Prognosis
15
2019
3519
0.580
 Why?
Fluorodeoxyglucose F18
3
2012
120
0.580
 Why?
Pancoast Syndrome
1
2013
2
0.580
 Why?
Radiopharmaceuticals
3
2012
163
0.570
 Why?
Treatment Outcome
12
2020
7472
0.560
 Why?
Male
36
2021
39938
0.550
 Why?
Fas Ligand Protein
1
2013
48
0.540
 Why?
Positron-Emission Tomography
5
2013
265
0.530
 Why?
Middle Aged
29
2021
24492
0.530
 Why?
Aged
24
2020
17612
0.520
 Why?
Fluorine Radioisotopes
1
2012
14
0.510
 Why?
Cyclooxygenase 2
1
2012
94
0.490
 Why?
Skin Neoplasms
1
2016
510
0.490
 Why?
Radiation Injuries
2
2010
161
0.490
 Why?
Neurosurgical Procedures
1
2013
174
0.480
 Why?
Bronchogenic Cyst
1
2010
5
0.470
 Why?
Radium
2
2020
5
0.470
 Why?
Thoracic Wall
1
2010
20
0.460
 Why?
Soft Tissue Infections
1
2010
21
0.460
 Why?
Thoracic Diseases
1
2010
29
0.460
 Why?
Clinical Trials as Topic
4
2020
1157
0.440
 Why?
United States
10
2020
5848
0.440
 Why?
Survival Analysis
4
2019
1565
0.410
 Why?
Thoracic Surgery, Video-Assisted
3
2016
22
0.410
 Why?
Adult
23
2021
24687
0.400
 Why?
Health Status Disparities
1
2011
134
0.400
 Why?
Neoplasm Proteins
1
2012
530
0.380
 Why?
Neoadjuvant Therapy
3
2020
258
0.370
 Why?
Chemotherapy, Adjuvant
3
2019
478
0.370
 Why?
Dumping Syndrome
1
2006
5
0.340
 Why?
Healthcare Disparities
1
2011
300
0.340
 Why?
Gastric Emptying
1
2006
19
0.340
 Why?
Retrospective Studies
9
2020
6816
0.330
 Why?
Aged, 80 and over
14
2016
6299
0.320
 Why?
Deglutition Disorders
1
2006
81
0.320
 Why?
Wounds, Nonpenetrating
1
2006
62
0.320
 Why?
Antineoplastic Agents
5
2020
2307
0.320
 Why?
Stomach
1
2006
117
0.310
 Why?
Esophageal Diseases
1
2005
30
0.310
 Why?
Gastroesophageal Reflux
1
2006
110
0.310
 Why?
Transcription Factors
1
2013
1455
0.310
 Why?
Patient Care Management
2
2020
29
0.310
 Why?
Intubation, Intratracheal
1
2006
129
0.300
 Why?
Survival Rate
8
2016
1896
0.300
 Why?
Patient Selection
3
2020
674
0.300
 Why?
Coronavirus Infections
2
2020
287
0.300
 Why?
Pneumonia, Viral
2
2020
313
0.290
 Why?
General Surgery
1
2007
208
0.290
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2011
2187
0.280
 Why?
Hamartoma
1
2003
34
0.280
 Why?
Risk Assessment
6
2020
2155
0.270
 Why?
Medical Oncology
1
2007
299
0.270
 Why?
Antibodies, Neutralizing
2
2021
117
0.270
 Why?
Negative-Pressure Wound Therapy
2
2014
9
0.270
 Why?
Carcinoma, Bronchogenic
1
2002
32
0.260
 Why?
Lymphatic Metastasis
4
2010
499
0.260
 Why?
Education, Medical, Graduate
2
2019
306
0.240
 Why?
Neoplasm Metastasis
3
2019
1015
0.240
 Why?
Funnel Chest
1
2021
7
0.240
 Why?
Pneumothorax
2
2020
49
0.240
 Why?
Chemoradiotherapy
2
2020
242
0.240
 Why?
Lung Diseases
1
2003
279
0.230
 Why?
Immunization, Passive
1
2020
77
0.230
 Why?
SEER Program
2
2011
191
0.220
 Why?
Critical Pathways
1
2020
34
0.220
 Why?
Sexual Harassment
1
2019
5
0.220
 Why?
Riots
1
2019
1
0.210
 Why?
Case-Control Studies
4
2013
1747
0.210
 Why?
Nontuberculous Mycobacteria
1
2018
8
0.210
 Why?
Protein Isoforms
2
2010
260
0.210
 Why?
Mycobacterium Infections, Nontuberculous
1
2018
18
0.200
 Why?
Drainage
1
2020
169
0.200
 Why?
Pandemics
2
2020
390
0.200
 Why?
Randomized Controlled Trials as Topic
2
2020
817
0.200
 Why?
Thoracotomy
1
2018
51
0.190
 Why?
Immunoglobulin G
1
2020
458
0.190
 Why?
Cost-Benefit Analysis
1
2020
381
0.190
 Why?
Radiotherapy, Adjuvant
2
2013
303
0.190
 Why?
Respiratory System
1
2018
105
0.190
 Why?
Periodicals as Topic
1
2020
165
0.190
 Why?
Cohort Studies
5
2012
2526
0.190
 Why?
Diagnosis, Differential
4
2013
1578
0.190
 Why?
Wound Closure Techniques
1
2017
12
0.190
 Why?
Consolidation Chemotherapy
1
2017
21
0.180
 Why?
Thoracic Neoplasms
1
2017
61
0.180
 Why?
Prosthesis-Related Infections
1
2017
46
0.180
 Why?
Evidence-Based Medicine
2
2017
430
0.170
 Why?
Risk Factors
4
2013
5095
0.170
 Why?
Lymph Nodes
2
2011
517
0.170
 Why?
Meta-Analysis as Topic
4
2016
103
0.160
 Why?
Asbestos
2
2012
22
0.160
 Why?
National Cancer Institute (U.S.)
1
2015
62
0.160
 Why?
Defibrillators, Implantable
1
2017
121
0.160
 Why?
Cell Proliferation
2
2013
1551
0.160
 Why?
Surgical Wound Infection
1
2017
178
0.160
 Why?
Forecasting
1
2016
305
0.160
 Why?
Subcutaneous Emphysema
1
2014
6
0.160
 Why?
Biopsy
2
2016
1128
0.160
 Why?
Photochemotherapy
1
1995
97
0.150
 Why?
Simian virus 40
4
1998
34
0.150
 Why?
Immunotherapy
1
2020
489
0.150
 Why?
Apoptosis
2
2013
1745
0.150
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2013
914
0.150
 Why?
Area Under Curve
2
2012
340
0.150
 Why?
Receptor, EphB2
1
2013
2
0.140
 Why?
Radiography
2
2014
863
0.140
 Why?
Neoplasm, Residual
2
2019
123
0.140
 Why?
Neoplasm Invasiveness
2
2013
522
0.140
 Why?
Peritoneum
1
2013
47
0.140
 Why?
Protein Kinase Inhibitors
1
2018
539
0.140
 Why?
Clinical Protocols
1
2013
154
0.130
 Why?
Epithelium
1
2013
311
0.130
 Why?
ROC Curve
2
2012
773
0.130
 Why?
Blotting, Western
2
2013
830
0.130
 Why?
Pain Management
1
2013
107
0.130
 Why?
Clinical Trials, Phase III as Topic
2
2007
145
0.130
 Why?
Occupational Exposure
1
2012
67
0.130
 Why?
Extracellular Matrix Proteins
1
2012
132
0.120
 Why?
Job Satisfaction
1
2012
63
0.120
 Why?
Postoperative Complications
2
2020
2190
0.120
 Why?
Solitary Pulmonary Nodule
1
2013
173
0.120
 Why?
Radiotherapy, Computer-Assisted
1
2011
24
0.120
 Why?
Young Adult
5
2021
5498
0.120
 Why?
Palliative Care
1
2013
243
0.120
 Why?
Sternoclavicular Joint
1
2010
2
0.120
 Why?
Carcinoma, Large Cell
1
2011
41
0.120
 Why?
Pulmonary Surgical Procedures
1
2010
3
0.120
 Why?
Colony-Forming Units Assay
1
2010
43
0.120
 Why?
Internship and Residency
1
2019
837
0.120
 Why?
Opioid-Related Disorders
1
2012
101
0.120
 Why?
Cranial Irradiation
2
2020
36
0.120
 Why?
Ribonucleases
1
2011
87
0.110
 Why?
Debridement
1
2010
66
0.110
 Why?
Models, Anatomic
1
2011
89
0.110
 Why?
Computer-Assisted Instruction
1
2011
44
0.110
 Why?
Cell Movement
2
2013
733
0.110
 Why?
Epithelial-Mesenchymal Transition
1
2010
64
0.110
 Why?
Functional Laterality
1
2011
203
0.110
 Why?
Models, Cardiovascular
1
2011
98
0.110
 Why?
Necrosis
1
2010
202
0.110
 Why?
Tumor Burden
2
2011
271
0.110
 Why?
Tuberculosis
1
2010
61
0.110
 Why?
Joint Diseases
1
2010
49
0.110
 Why?
Tumor Cells, Cultured
3
2009
1089
0.110
 Why?
Oligonucleotide Array Sequence Analysis
2
2010
699
0.110
 Why?
Tracheal Neoplasms
1
2009
7
0.110
 Why?
Prospective Studies
5
2018
3719
0.110
 Why?
Glomus Tumor
1
2009
5
0.110
 Why?
Cell Line, Tumor
3
2011
2326
0.110
 Why?
Pain, Postoperative
1
2012
209
0.110
 Why?
Antibodies, Monoclonal
1
2017
1479
0.110
 Why?
Chest Pain
1
2009
40
0.110
 Why?
Cell Adhesion
1
2010
424
0.100
 Why?
Sarcoidosis
1
2010
89
0.100
 Why?
MicroRNAs
2
2011
464
0.100
 Why?
Enzyme-Linked Immunosorbent Assay
1
2010
400
0.100
 Why?
Endosonography
1
2010
126
0.100
 Why?
Mediastinal Neoplasms
2
2005
51
0.100
 Why?
Length of Stay
2
2020
641
0.100
 Why?
Analgesics, Opioid
1
2012
314
0.100
 Why?
Microwaves
1
2008
28
0.100
 Why?
RNA, Messenger
2
2013
1971
0.090
 Why?
Wound Healing
1
2010
334
0.090
 Why?
NF-kappa B
1
2011
414
0.090
 Why?
Chest Tubes
2
2020
20
0.090
 Why?
Vascular Endothelial Growth Factor A
1
2009
369
0.090
 Why?
Time Factors
3
2012
5346
0.090
 Why?
DNA, Viral
2
1998
267
0.090
 Why?
Receptor, IGF Type 1
2
1998
42
0.090
 Why?
Sex Factors
1
2011
1059
0.090
 Why?
African Continental Ancestry Group
1
2010
555
0.090
 Why?
Pulmonary Ventilation
1
2006
36
0.090
 Why?
Neovascularization, Pathologic
1
2009
364
0.090
 Why?
Gene Expression Profiling
2
2010
1311
0.090
 Why?
Diagnostic Imaging
1
2011
436
0.090
 Why?
Cognition
1
2011
468
0.090
 Why?
Sialoglycoproteins
1
2006
35
0.080
 Why?
Carbonic Anhydrases
1
2006
13
0.080
 Why?
Mediastinoscopy
1
2005
6
0.080
 Why?
Sex Distribution
1
2006
172
0.080
 Why?
Computer Simulation
1
2011
1016
0.080
 Why?
Thoracic Injuries
1
2006
29
0.080
 Why?
Disease-Free Survival
2
2011
1200
0.080
 Why?
California
1
2006
131
0.080
 Why?
Hemangioendothelioma, Epithelioid
1
2005
9
0.080
 Why?
History, 21st Century
2
2017
174
0.080
 Why?
Esophagoplasty
1
2005
9
0.080
 Why?
Anesthetics
1
2005
57
0.080
 Why?
Radiotherapy Dosage
1
2006
456
0.080
 Why?
Blood Loss, Surgical
1
2005
104
0.080
 Why?
European Continental Ancestry Group
1
2010
1063
0.080
 Why?
Risk
1
2006
689
0.070
 Why?
Peritoneal Neoplasms
2
1998
193
0.070
 Why?
Antigens, Neoplasm
1
2006
295
0.070
 Why?
Follow-Up Studies
3
2016
3681
0.070
 Why?
Adolescent
3
2021
8667
0.070
 Why?
Preoperative Care
1
2005
405
0.060
 Why?
Asthma
1
2009
794
0.060
 Why?
Smoking
1
2006
557
0.060
 Why?
Hospital Mortality
1
2003
298
0.060
 Why?
Cross Reactions
1
2021
133
0.060
 Why?
Transfection
3
2011
937
0.060
 Why?
Oxygen
1
2006
678
0.060
 Why?
Antigens, Viral
1
2021
157
0.060
 Why?
Immunity, Humoral
1
2021
66
0.060
 Why?
Bioethics
1
2020
34
0.060
 Why?
Risk Management
1
2020
45
0.060
 Why?
Etoposide
1
2020
196
0.050
 Why?
Epitopes
1
2021
297
0.050
 Why?
Asbestosis
2
1998
5
0.050
 Why?
Practice Guidelines as Topic
2
2018
1060
0.050
 Why?
Phosphoproteins
1
2021
263
0.050
 Why?
Sputum
1
2018
25
0.050
 Why?
Interdisciplinary Communication
1
2020
133
0.050
 Why?
Tumor Virus Infections
1
1998
82
0.050
 Why?
Bronchoalveolar Lavage Fluid
1
2018
125
0.050
 Why?
Infection Control
1
2020
130
0.050
 Why?
Self Report
1
2019
238
0.050
 Why?
Oligonucleotides, Antisense
1
1998
70
0.050
 Why?
Electrocardiography
1
2021
533
0.050
 Why?
Regulatory Sequences, Nucleic Acid
1
1998
142
0.050
 Why?
RNA, Ribosomal, 16S
1
2018
230
0.050
 Why?
Heart
1
2021
504
0.050
 Why?
Pilot Projects
2
2012
774
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2018
140
0.040
 Why?
RNA, Antisense
1
1996
16
0.040
 Why?
Papillomavirus Infections
1
1998
145
0.040
 Why?
Feasibility Studies
2
1996
703
0.040
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
1996
17
0.040
 Why?
Receptor, erbB-2
1
2018
188
0.040
 Why?
Comorbidity
1
2020
870
0.040
 Why?
Anniversaries and Special Events
1
2016
10
0.040
 Why?
Protein-Tyrosine Kinases
1
2018
295
0.040
 Why?
Sensitivity and Specificity
2
2012
2074
0.040
 Why?
Proto-Oncogene Proteins c-met
1
2018
209
0.040
 Why?
Consensus
1
2017
254
0.040
 Why?
Radiation Oncology
1
2017
100
0.040
 Why?
B-Lymphocytes
1
2021
760
0.040
 Why?
Chromosome Disorders
1
1995
122
0.040
 Why?
National Institutes of Health (U.S.)
1
1995
99
0.040
 Why?
Heart Ventricles
1
2021
713
0.040
 Why?
Genes, Tumor Suppressor
1
1995
166
0.040
 Why?
Clinical Trials, Phase II as Topic
1
1995
169
0.040
 Why?
Clinical Trials, Phase I as Topic
1
1995
152
0.040
 Why?
History, 20th Century
1
2016
314
0.040
 Why?
Base Sequence
2
1996
2399
0.040
 Why?
Proto-Oncogene Proteins
1
2018
657
0.040
 Why?
Genetic Testing
1
2018
475
0.030
 Why?
Chromosome Aberrations
1
1995
397
0.030
 Why?
DNA Damage
1
1995
344
0.030
 Why?
Molecular Sequence Data
2
1996
3166
0.030
 Why?
Immunohistochemistry
1
2018
1783
0.030
 Why?
Immunoenzyme Techniques
1
2013
329
0.030
 Why?
Pleural Effusion, Malignant
1
2012
12
0.030
 Why?
Pleural Effusion
1
2012
48
0.030
 Why?
Fluorescent Antibody Technique
1
2013
336
0.030
 Why?
Cricetinae
3
1998
576
0.030
 Why?
Reactive Oxygen Species
1
1995
448
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2013
280
0.030
 Why?
Fear
1
2012
63
0.030
 Why?
Tumor Necrosis Factor-alpha
1
1996
677
0.030
 Why?
Self Concept
1
2012
132
0.030
 Why?
Recurrence
1
2014
1125
0.030
 Why?
Cytokines
1
1995
712
0.030
 Why?
Thoracoscopes
1
2011
2
0.030
 Why?
Surgical Staplers
1
2011
11
0.030
 Why?
RNA, Small Interfering
1
2013
566
0.030
 Why?
Dissection
1
2011
45
0.030
 Why?
Taxoids
1
2011
131
0.030
 Why?
Computer Graphics
1
2011
99
0.030
 Why?
Carboplatin
1
2011
244
0.030
 Why?
Community-Based Participatory Research
1
2010
37
0.030
 Why?
Motor Skills
1
2011
75
0.030
 Why?
Radiography, Thoracic
1
2013
403
0.030
 Why?
Patient Positioning
1
2011
64
0.030
 Why?
Child
1
2021
6303
0.030
 Why?
Mediastinum
1
2010
46
0.030
 Why?
Kaplan-Meier Estimate
1
2012
896
0.030
 Why?
Affect
1
2012
377
0.030
 Why?
Biopsy, Needle
1
2010
268
0.030
 Why?
Multivariate Analysis
1
2012
1008
0.030
 Why?
Down-Regulation
1
2011
514
0.030
 Why?
Longitudinal Studies
1
2012
899
0.030
 Why?
Depression
1
2012
375
0.020
 Why?
Empyema
1
2008
11
0.020
 Why?
Cells, Cultured
1
2013
2901
0.020
 Why?
Gene Expression Regulation, Neoplastic
2
2006
1171
0.020
 Why?
Insulin-Like Growth Factor I
2
1998
116
0.020
 Why?
Plasmids
2
1998
291
0.020
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.020
 Why?
Tracheal Diseases
1
2005
11
0.020
 Why?
Lymphatic Diseases
1
2005
38
0.020
 Why?
Regression Analysis
1
2007
618
0.020
 Why?
Incidence
1
2010
1540
0.020
 Why?
Age Factors
1
2010
1860
0.020
 Why?
Clinical Competence
1
2011
664
0.020
 Why?
Polymerase Chain Reaction
2
1998
988
0.020
 Why?
Predictive Value of Tests
1
2010
1626
0.020
 Why?
Animals
4
1998
25944
0.020
 Why?
Lymphoma, Non-Hodgkin
1
2005
258
0.020
 Why?
Reproducibility of Results
1
2010
2574
0.020
 Why?
Disease Progression
1
2007
1385
0.020
 Why?
Lung
1
2006
1025
0.010
 Why?
Gene Expression Regulation, Viral
1
1998
89
0.010
 Why?
HSP70 Heat-Shock Proteins
1
1998
108
0.010
 Why?
Virus Replication
1
1998
319
0.010
 Why?
Oxygenators
1
1996
3
0.010
 Why?
Carcinoma, Adenoid Cystic
1
1996
22
0.010
 Why?
Sarcoma, Ewing
1
1996
40
0.010
 Why?
Cardiac Output
1
1996
150
0.010
 Why?
Safety
1
1996
164
0.010
 Why?
Hyperthermia, Induced
1
1996
73
0.010
 Why?
Cell Transformation, Neoplastic
1
1998
407
0.010
 Why?
Cell Division
1
1996
757
0.010
 Why?
Pulmonary Artery
1
1996
286
0.010
 Why?
Remission Induction
1
1996
689
0.010
 Why?
Interferon-gamma
1
1996
436
0.010
 Why?
Sarcoma
1
1996
224
0.010
 Why?
Carcinoma, Renal Cell
1
1996
355
0.010
 Why?
Melanoma
1
1996
470
0.010
 Why?
Transcription, Genetic
1
1996
1146
0.010
 Why?
Blood Pressure
1
1996
1147
0.010
 Why?
Rats
1
1996
4296
0.010
 Why?
Donington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (361) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_